Champions Oncology reports record annual revenue $57M (+14%), net income $4.6M for FY2025

CHAMPIONS ONCOLOGY, INC.

Record annual revenue $57M, up 14% YoY; net income $4.6M vs loss of $7.4M prior year.
Adjusted EBITDA income $7.1M (vs loss of $3.9M); year-end cash $9.8M with no debt.
Q4 revenue $12.3M, down 12% YoY; Q4 adjusted EBITDA loss of $1.2M.
Data license revenue contributed $4.7M for fiscal year; new high-margin data business launched.
CEO cites return to growth and profitability; strong pipeline for FY2026.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.